Gilead Sciences to Pay $202 Million to Settle Claims They Used Speaker Programs to Pay Kickbacks to Doctors

Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle civil claims that the drugmaker used speaker programs to pay kickbacks to doctors to induce them to prescribe Gilead’s expensive antiretroviral medications to patients with HIV, prosecutors announced Tuesday.

Gilead gave the money to doctors who spoke at HIV Speaker Program events in the form of honoraria payments, meals and travel expenses, according to the U.S. Attorney’s Office in Manhattan, which said the programs spanned from 2011 through 2017.

Read more at CNBC